Skip to main content

Find Clinical Trials

Home
Conditions
Hepatitis C, Chronic

Clinical trial condition

Hepatitis C, Chronic

Explore clinical trials studying Hepatitis C, Chronic. Study availability and eligibility vary by location and protocol.

699 public trials 3 recruiting studies

Refine in advanced search Browse all conditions

Hepatitis C, Chronic trial results

Completed

Ombitasvir/ABT-450 (Paritaprevir)/Ritonavir With Dasabuvir and Ribavirin (RBV) in Treatment Naive and Treatment Experienced Genotype 1a Hepatitis C Virus Infected Adults

NCT02476617

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +17 more
Locations: Not specified

View Trial Details

Completed

A Study of Extended Therapy of PEGASYS (Peginterferon Alfa-2a) in Combination With COPEGUS (Ribavirin) in Patients With Chronic Hepatitis C and Slow Response

NCT01033448

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: Haemek Hospital; Gastroenterology Afula, Israel

Clalit City Ashdod MC; Liver Clinic Ashdod, Israel

Batyamon; Liver Unit Bat Yam, Israel

Soroka Medical Center; Gastroenterology Beersheba, Israel

View all 20 locations

View Trial Details

Completed

A Study of Predictors of the Effectiveness of Pegylated Interferon in a Cohort of Participants With Hepatitis C

NCT01659567

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: Hepatology Clinic Hepa Tbilisi, Georgia

Infectious Diseases, AIDS and Clinical Immunology Research Center Tbilisi, Georgia

Ltd Mrcheveli Tbilisi, Georgia

View Trial Details

Completed

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ABT-493 and ABT-530 With and Without Ribavirin in Adults With HCV Who Failed a Prior DAA Containing Therapy

NCT02446717

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +18 more
Locations: Not specified

View Trial Details

Completed

Interferon/Ribavirin-Free Sofosbuvir Based Treatment (AURIC)

NCT02628717

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +17 more
Locations: Medical University of Vienna Vienna, Austria

View Trial Details

Completed

A Randomized, Open-Label Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir Co-administered With Ribavirin (RBV) in Adults With Genotype 4 Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis (AGATE-1)

NCT02265237

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +15 more
Locations: Not specified

View Trial Details

Completed

Phase I Trial to Evaluate the Safety, Tolerability and Immunogenicity of VGX-6150 for Second-line Therapy of Chronic Hepatitis C Infection

NCT02027116

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: Pusan National University Hospital Pusan, South Korea

Yonsei University Severance Hospital Seoul, South Korea

View Trial Details

Completed

A Study to Evaluate the Efficacy and Safety of Three Experimental Drugs in Adults With Hepatitis C Virus Infection, Who Are Either Treatment-naive or Treatment-experienced in Brazil

NCT02442271

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C Infection, +15 more
Locations: Not specified

View Trial Details

Completed

Randomized Clinical Trial of Sofosbuvir in Combination With Daclatasvir or Simeprevir for 12 Weeks in Non-cirrhotic Subjects Infected With Chronic Hepatitis C Virus Genotype 1 (TNT)

NCT02624063

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: Outpatient Clinic of Viral Hepatitis (NUPAIG) São Paulo, Brazil

View Trial Details

Completed

SR-BI and Antiviral Treatment Response in HCV

NCT02714712

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +15 more
Locations: Not specified

View Trial Details